From Medscape Pulmonary Medicine

Coverage from

CHEST 2018: American College of Chest Physicians Annual Meeting

October 06 - 10, 2018; San Antonio, Texas

October 06 - 10, 2018 San Antonio, Texas

CHEST 2018 LAMAs Are Safe Irrespective of Cardiovascular Risk in COPD Long-acting antimuscarinic antagonists are safe for patients with chronic obstructive pulmonary disease and will not increase the risk for a cardiovascular event, new data show.
Medscape Medical News, October 10, 2018

Conference News

CHEST 2018 Embolism Recommendations Not Followed by Many Hospitals
Medscape Medical News, October 12, 2018
CHEST 2018 Low-Cost Program Slashes Readmission Rates for COPD
Medscape Medical News, October 11, 2018
CHEST 2018 LAMAs Are Safe Irrespective of Cardiovascular Risk in COPD
Medscape Medical News, October 10, 2018

CHEST 2018 Good Asthma Control Trumps Triggers in Kids With Asthma
Medscape Medical News, October 8, 2018
CHEST 2018 New Drug Combinations for Asthma, COPD at CHEST 2018
Medscape Medical News, October 1, 2018

Popular News From CHEST 2017

Landmark Trials Deliver Evidence to Rethink Saline Use The results could transform the way fluids are administered to some 5 million patients in an effort to lower the risk for renal dysfunction and death.
Medscape Medical News, Nov 02, 2017
New Drug Promising for Excessive Sleepiness Solriamfetol has a neurotransmitter profile that is different from other alerting agents that induce wakefulness in patients with obstructive sleep apnea who are excessively sleepy.
Medscape Medical News, Oct 30, 2017
Bronchoscopy Effective for Diagnosis Only Half the Time The diagnostic success of bronchoscopy might not be as high as has been believed, new research warns.
Medscape Medical News, Nov 06, 2017

Medscape Pulmonary Medicine© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Previous Coverage

Related Resources